A new strategy based on drug-linker-nanocarrier interactions to design new HIV-1 non-nucleoside reverse transcriptase inhibitors.
Saved in:
| Title: | A new strategy based on drug-linker-nanocarrier interactions to design new HIV-1 non-nucleoside reverse transcriptase inhibitors. |
|---|---|
| Authors: | Yoosefian M; Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran., Mirhaji E; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Esmaeili A; Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran. |
| Source: | Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2026 Feb; Vol. 44 (2), pp. 797-808. Date of Electronic Publication: 2025 May 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-0254 (Electronic) Linking ISSN: 07391102 NLM ISO Abbreviation: J Biomol Struct Dyn Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-0254 |
|---|---|
| DOI: | 10.1080/07391102.2025.2507814 |
